These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 31144815)

  • 1. Application of Free Energy Perturbation (FEP+) to Understanding Ligand Selectivity: A Case Study to Assess Selectivity Between Pairs of Phosphodiesterases (PDE's).
    Moraca F; Negri A; de Oliveira C; Abel R
    J Chem Inf Model; 2019 Jun; 59(6):2729-2740. PubMed ID: 31144815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational and in vitro binding studies of theophylline against phosphodiesterases functioning in sperm in presence and absence of pentoxifylline.
    Raj G; Nitin K; Abhishek S; Dey S; Rajakumara E
    Biophys Chem; 2024 Oct; 313():107294. PubMed ID: 39029164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model.
    Landucci E; Ribaudo G; Anyanwu M; Oselladore E; Giannangeli M; Mazzantini C; Lana D; Giovannini MG; Memo M; Pellegrini-Giampietro DE; Gianoncelli A
    ACS Chem Neurosci; 2023 Oct; 14(20):3826-3838. PubMed ID: 37726213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative Binding Free Energy Calculations Applied to Protein Homology Models.
    Cappel D; Hall ML; Lenselink EB; Beuming T; Qi J; Bradner J; Sherman W
    J Chem Inf Model; 2016 Dec; 56(12):2388-2400. PubMed ID: 28024402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the catalytic mechanism of human phosphodiesterase 9.
    Liu S; Mansour MN; Dillman KS; Perez JR; Danley DE; Aeed PA; Simons SP; Lemotte PK; Menniti FS
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13309-14. PubMed ID: 18757755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free energy perturbation (FEP)-guided scaffold hopping.
    Wu D; Zheng X; Liu R; Li Z; Jiang Z; Zhou Q; Huang Y; Wu XN; Zhang C; Huang YY; Luo HB
    Acta Pharm Sin B; 2022 Mar; 12(3):1351-1362. PubMed ID: 35530128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.
    Seebeck T; Sterk GJ; Ke H
    Future Med Chem; 2011 Aug; 3(10):1289-306. PubMed ID: 21859303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A machine learning-based method to improve docking scoring functions and its application to drug repurposing.
    Kinnings SL; Liu N; Tonge PJ; Jackson RM; Xie L; Bourne PE
    J Chem Inf Model; 2011 Feb; 51(2):408-19. PubMed ID: 21291174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranking Reversible Covalent Drugs: From Free Energy Perturbation to Fragment Docking.
    Zhang H; Jiang W; Chatterjee P; Luo Y
    J Chem Inf Model; 2019 May; 59(5):2093-2102. PubMed ID: 30763080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using AlphaFold and Experimental Structures for the Prediction of the Structure and Binding Affinities of GPCR Complexes via Induced Fit Docking and Free Energy Perturbation.
    Coskun D; Lihan M; Rodrigues JPGLM; Vass M; Robinson D; Friesner RA; Miller EB
    J Chem Theory Comput; 2024 Jan; 20(1):477-489. PubMed ID: 38100422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FEP Protocol Builder: Optimization of Free Energy Perturbation Protocols Using Active Learning.
    de Oliveira C; Leswing K; Feng S; Kanters R; Abel R; Bhat S
    J Chem Inf Model; 2023 Sep; 63(17):5592-5603. PubMed ID: 37594480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncovering the selectivity mechanism of phosphodiesterase 7A/8A inhibitors through computational studies.
    Wang Z; Wang S; Wang H; Hu B; Qi Z; Zhang Y; Song P; Cai Q; Yang H; Wang J
    Phys Chem Chem Phys; 2024 Apr; 26(15):11770-11781. PubMed ID: 38566586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaffold Hopping and Optimization of Small Molecule Soluble Adenyl Cyclase Inhibitors Led by Free Energy Perturbation.
    Sun S; Fushimi M; Rossetti T; Kaur N; Ferreira J; Miller M; Quast J; van den Heuvel J; Steegborn C; Levin LR; Buck J; Myers RW; Kargman S; Liverton N; Meinke PT; Huggins DJ
    J Chem Inf Model; 2023 May; 63(9):2828-2841. PubMed ID: 37060320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal designs for pairwise calculation: An application to free energy perturbation in minimizing prediction variability.
    Yang Q; Burchett W; Steeno GS; Liu S; Yang M; Mobley DL; Hou X
    J Comput Chem; 2020 Jan; 41(3):247-257. PubMed ID: 31721260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The maximal and current accuracy of rigorous protein-ligand binding free energy calculations.
    Ross GA; Lu C; Scarabelli G; Albanese SK; Houang E; Abel R; Harder ED; Wang L
    Commun Chem; 2023 Oct; 6(1):222. PubMed ID: 37838760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enabling structure-based drug discovery utilizing predicted models.
    Miller EB; Hwang H; Shelley M; Placzek A; Rodrigues JPGLM; Suto RK; Wang L; Akinsanya K; Abel R
    Cell; 2024 Feb; 187(3):521-525. PubMed ID: 38306979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FEP Augmentation as a Means to Solve Data Paucity Problems for Machine Learning in Chemical Biology.
    Burger PB; Hu X; Balabin I; Muller M; Stanley M; Joubert F; Kaiser TM
    J Chem Inf Model; 2024 May; 64(9):3812-3825. PubMed ID: 38651738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIES 2.0: A Dual-Topology Open Source Relative Binding Free Energy Builder with Web Portal.
    Bieniek MK; Wade AD; Bhati AP; Wan S; Coveney PV
    J Chem Inf Model; 2023 Feb; 63(3):718-724. PubMed ID: 36719676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations.
    Drilon A; Horan JC; Tangpeerachaikul A; Besse B; Ou SI; Gadgeel SM; Camidge DR; van der Wekken AJ; Nguyen-Phuong L; Acker A; Keddy C; Nicholson KS; Yoda S; Mente S; Sun Y; Soglia JR; Kohl NE; Porter JR; Shair MD; Zhu V; Davare MA; Hata AN; Pelish HE; Lin JJ
    Cancer Discov; 2023 Mar; 13(3):598-615. PubMed ID: 36511802
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.